Evidence map›Paper›PMID 34931806›Full record

ArticleACS chemical biology2022

4-Deoxy-4-fluoro-GalNAz (4FGalNAz) Is a Metabolic Chemical Reporter of O-GlcNAc Modifications, Highlighting the Notable Substrate Flexibility of O-GlcNAc Transferase.

Emma G Jackson, Giuliano Cutolo, Bo Yang, Nageswari Yarravarapu, Mary W N Burns, Ganka Bineva-Todd, Chloë Roustan, James B Thoden, Halley M Lin-Jones, Toin H van Kuppevelt and 5 more

Open access · hybridAbstract read
In one paragraph

Article in ACS chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Iterative Bump-and-Hole Engineering Creates a Bioorthogonal Reporter forJournal of the American Chemical Society · 2026
    Article
  4. Article
  5. Article
  6. Iterative Bump-and-hole engineering creates a bioorthogonal reporter forbioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. A Bioorthogonal Precision Tool for HumanJournal of the American Chemical Society · 2024
    Article
  9. Promiscuous Enzymes for Residue-Specific Peptide and Protein Late-Stage Functionalization.Chembiochem : a European journal of chemical biology · 2023
    Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Emma G JacksonDepartments of Chemistry, University of Southern California, Los Angeles, California 90089, United States.
Giuliano CutoloDepartments of Chemistry, University of Southern California, Los Angeles, California 90089, United States.
Bo YangDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, United States.ORCID 0000-0003-3534-7517
Nageswari YarravarapuDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.ORCID 0000-0002-1975-0077
Mary W N BurnsDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.
Ganka Bineva-ToddChemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom.
Chloë RoustanStructural Biology Science Technology Platform, The Francis Crick Institute, NW1 1AT London, United Kingdom.
James B ThodenDepartment of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706, United States.
Halley M Lin-JonesDepartments of Chemistry, University of Southern California, Los Angeles, California 90089, United States.
Toin H van KuppeveltDepartment of Biochemistry, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, 6500 HB Nijmegen The Netherlands.
Hazel M HoldenDepartment of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706, United States.
Benjamin SchumannChemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom.ORCID 0000-0001-5504-0147
Jennifer J KohlerDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.ORCID 0000-0001-5373-3329
Christina M WooDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, United States.ORCID 0000-0001-8687-9105
Matthew R PrattDepartments of Chemistry, University of Southern California, Los Angeles, California 90089, United States.ORCID 0000-0003-3205-5615
University of Southern California · USThe Francis Crick Institute · GBThe University of Texas Southwestern Medical Center · USHarvard University · USUniversity of Wisconsin–Madison · USRadboud University Nijmegen · NL

Funding

Chemical Tools for the Investigation and Manipulation of Protein GlycosylationR01GM125939 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI PRATT, MATTHEW ROBERT · 2017 to 2025
$2.4M
Biochemical Investigations of Sugar-Modifying EnzymesR35GM134643 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI HOLDEN, HAZEL M. · 2020 to 2024
$2.0M
Tools to facilitate manipulation of protein-specific glycosylation stoichiometry in cellsU01CA242098 · NCI · HARVARD UNIVERSITY · PI WOO, CHRISTINA · 2019 to 2021
$1.4M
Chemistry-Biology Interface T32T32GM127216 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI KOHLER, JENNIFER J, PHILLIPS, MARGARET A. · 2019 to 2023
$754k
Discovery of small molecule inhibitors of GalNAc-type O-linked glycosylationR01GM130096 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI KOHLER, JENNIFER J, POSNER, BRUCE ARTHUR · 2018 to 2019
$576k
Medical Research Council FC001749NCI NIH HHS U01 CA242098NIGMS NIH HHS R01 GM125939NIGMS NIH HHS R01 GM130096NIGMS NIH HHS R35 GM134643NIGMS NIH HHS T32 GM127216Wellcome Trust FC001749
6 · The paper itself

Abstract

Bio-orthogonal chemistries have revolutionized many fields. For example, metabolic chemical reporters (MCRs) of glycosylation are analogues of monosaccharides that contain a bio-orthogonal functionality, such as azides or alkynes. MCRs are metabolically incorporated into glycoproteins by living systems, and bio-orthogonal reactions can be subsequently employed to install visualization and enrichment tags. Unfortunately, most MCRs are not selective for one class of glycosylation (e.g., N-linked vs O-linked), complicating the types of information that can be gleaned. We and others have successfully created MCRs that are selective for intracellular O-GlcNAc modification by altering the structure of the MCR and thus biasing it to certain metabolic pathways and/or O-GlcNAc transferase (OGT). Here, we attempt to do the same for the core GalNAc residue of mucin O-linked glycosylation. The most widely applied MCR for mucin O-linked glycosylation, GalNAz, can be enzymatically epimerized at the 4-hydroxyl to give GlcNAz. This results in a mixture of cell-surface and O-GlcNAc labeling. We reasoned that replacing the 4-hydroxyl of GalNAz with a fluorine would lock the stereochemistry of this position in place, causing the MCR to be more selective. After synthesis, we found that 4FGalNAz labels a variety of proteins in mammalian cells and does not perturb endogenous glycosylation pathways unlike 4FGalNAc. However, through subsequent proteomic and biochemical characterization, we found that 4FGalNAz does not widely label cell-surface glycoproteins but instead is primarily a substrate for OGT. Although these results are somewhat unexpected, they once again highlight the large substrate flexibility of OGT, with interesting and important implications for intracellular protein modification by a potential range of abiotic and native monosaccharides.

Indexed as

AcetylglucosamineAnimalsCHO CellsCricetinaeCricetulusGalactokinaseGalactosyltransferasesGene Expression RegulationGlycosaminoglycansN-AcetylglucosaminyltransferasesRecombinant ProteinsSubstrate SpecificityUridine Diphosphate Sugars4-fluoro-N-acetylhexosamine uridine diphosphateAcetylglucosamineGalactokinaseGalactosyltransferasesGALK2 protein, humanGlycosaminoglycansN-AcetylglucosaminyltransferasesO-GlcNAc transferaseRecombinant ProteinsUDP-GalNAc pyrophosphorylase AGX1, humanUDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferaseUridine Diphosphate Sugars

Identifiers

PMID34931806
PMCPMC8787749
OpenAlexW4200355295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.